BiotechTube

Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fed

Conditions

Fed

Trial Timeline

Oct 1, 2012 → Oct 1, 2012

NCT ID
NCT01827878

About Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets

Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets is a phase 1 stage product being developed by Ipca Laboratories for Fed. The current trial status is completed. This product is registered under clinical trial identifier NCT01827878. Target conditions include Fed.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT01831700Phase 1Completed
NCT01827878Phase 1Completed

Competing Products

20 competing products in Fed

See all competitors
ProductCompanyStageHype Score
Lamotrigine Tablets 25 mg + LamotrigineIpca LaboratoriesPhase 1
33
Levocetirizine Dihydrochloride tablets 5 mg + Levocetirizine DihydrochlorideIpca LaboratoriesPhase 1
33
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgIpca LaboratoriesPhase 1
33
Ondansetron Tablets USP 8 mg + Ondansetron HydrochlorideIpca LaboratoriesPhase 1
33
Risperidone Tablet 1 mg + RisperidoneIpca LaboratoriesPhase 1
33
Metoprolol Succinate ER Tablet 200 mg + 'TOPROL-XL®' ER Tablets 200 mgIpca LaboratoriesPhase 1
33
Bisoprolol Fumarate Tablet 10 mg + BisoprololIpca LaboratoriesPhase 1
33
Lisinopril Tablets 40 mg + LisinoprilIpca LaboratoriesPhase 1
33
Quetiapine Fumarate Tablets 25 mg + Quetiapine FumarateIpca LaboratoriesPhase 1
33
Etodolac Tablets USP 500mg + Etodolac Tablets USP 500 mgIpca LaboratoriesPhase 1
33
Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500 mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 5/500mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mg + Dapagliflozin/metformin XR 10/1000mgAstraZenecaPhase 1
33
Pantoprazole SodiumDr. Reddy's LaboratoriesPhase 1
30
DesloratadineDr. Reddy's LaboratoriesPhase 1
30
ReminylDr. Reddy's LaboratoriesPhase 1
30
OlanzapineDr. Reddy's LaboratoriesPhase 1
30
CIPRO®XRDr. Reddy's LaboratoriesPhase 1
30
Olanzapine OD Tablets 5 mgDr. Reddy's LaboratoriesPhase 1
30
Amlodipine Besylate/Benazepril HClDr. Reddy's LaboratoriesPhase 1
30
Mycophenolate MofetilDr. Reddy's LaboratoriesPhase 1
30
DexmethylphenidateCingulatePhase 1
25

Other Products from Ipca Laboratories

Metoprolol Succinate ER Tablets 50 mg + 'TOPROL-XL®' ER Tablets 50 mgPhase 1
33
Indomethacin Extended-Release Capsules USP 75 mg + Indomethacin Extended Release Capsules USP 75 mgPhase 1
33
Ondansetron Tablets USP 8 mg + Ondansetron HydrochloridePhase 1
33
Etodolac Capsules USP 300 mg + EtodolacPhase 1
33
Risperidone Tablet 1 mg + RisperidonePhase 1
33